JAMES CAREY: Open Payments
NPI 1053854083 · HARTSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 18 payments from 9 companies in 2025. Trend: 2023 $507 · 2024 $560 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $222 |
| Corcept Therapeutics | 4 | $158 |
| Novo Nordisk Inc | 2 | $36 |
| Astellas Pharma US Inc | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $22 |
| ABBVIE INC. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
Products named: Korlym, BREZTRI, AIRSUPRA, Veozah, CAPLYTA, FARXIGA, HETLIOZ, The Cologuard Plus Collection Kit.
Industry payments across TN — which companies pay providers there.
